Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$929,258,468
+$176,139,283 QoQ
Shares Held
9,555,357
+1.1% QoQ
Ownership
4.49%
of shares outstanding
% of Portfolio
5.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BAKER BROS. ADVISORS LP holds $16,600,149,582 across 76 Biotechnology names. RVMD ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,744,412 | $2,893,664,057 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,799,053 | $2,613,054,769 | |
| 3 | INSM |
INSMED Inc
|
7,421,111 | $1,213,500,070 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,141,701 | $1,121,116,222 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,896,690 | $954,880,319 | |
| 6 | RVMD |
Revolution Medicines, Inc.
This page
|
9,555,357 | $929,258,468 | |
| 7 | CELC |
Celcuity Inc.
|
7,915,792 | $903,508,498 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
19,919,186 | $759,319,370 |
All Filings in RVMD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $929,258,468 | 9,555,357 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $753,119,185 | 9,455,357 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $753,119,185 | 9,455,357 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $441,565,171 | 9,455,357 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $344,537,319 | 9,364,972 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $280,651,329 | 7,936,972 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $347,163,155 | 7,936,972 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $343,258,231 | 7,569,090 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $293,756,382 | 7,569,090 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $243,312,295 | 7,549,249 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $147,663,482 | 5,148,657 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $74,500,526 | 2,691,493 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $71,997,437 | 2,691,493 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $58,297,738 | 2,691,493 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,293,328 | 222,222 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,382,217 | 222,222 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,331,106 | 222,222 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,668,883 | 222,222 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,593,327 | 222,222 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,113,327 | 222,222 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,053,326 | 222,222 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,195,545 | 222,222 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||